Substandard drugs cheaper than generics they copy: peer review findings - Roger Bate

The Journal of Economics and Management Strategy has published our paper (Link), the first to statistically prove that substandard medicines are cheaper than the generics they copy. This is useful since it means that regulators (especially in emerging markets) can target more precisely the parts of the market likely to exhibit such problems. As predicted fake products are passed off at nearly identical pricing to the generics they copy, so market signals are not helpful in finding fakes.
© 2014 Safe Medicines Coalition Contact Us